New AAV Vectors Promise Safer Gene Therapy Delivery

WHY IT MATTERS

Could enable re-dosing of gene therapies and expand treatment to more patients.

Researchers developed engineered AAV vectors with reduced immunogenicity and improved tissue targeting.